IL257531B
Therapeutic combinations comprising anti-folr1 immunoconjugates
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| US2012009181A1 | Cites | United States of America | – | Search report | – |
| WO2015054400A2 | Cites | World Intellectual Property Organization (WIPO) | X | Search report | 1-5,9-15,20-40 |
36 members in 12 offices
Priority claims7
| Document | Office | Kind | Date |
|---|---|---|---|
| 62220028 | United States of America | – | |
| 201562220028 | United States of America | P | |
| 62242669 | United States of America | – | |
| 201562242669 | United States of America | P | |
| 62250756 | United States of America | – | |
| 201562250756 | United States of America | P | |
| 2016052231 | United States of America | W |
Members36
| Document | Office | Kind | |
|---|---|---|---|
| CA2994888A1 | Canada | A1 | |
| WO2017049149A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2017095571A1 | United States of America | A1 | |
| AU2016323968A1 | Australia | A1 | |
| IL257531A | Israel | A | |
| IL257531D0 | Israel | D0 | |
| KR20180053319A | Republic of Korea | A | |
| EP3349796A1 | European Patent Office (EPO) | A1 | |
| MA42844A | Morocco | A | |
| JP2018527383A | Japan | A | |
| CN108601828A | China | A | |
| US10172875B2 | United States of America | B2 | |
| EP3349796A4 | European Patent Office (EPO) | A4 | |
| US2019167704A1 | United States of America | A1 | |
| HK1255141A | Hong Kong, China | A | |
| HK1255141A1 | Hong Kong, China | A1 | |
| RU2018111205A | Russian Federation | A | |
| RU2018111205A3 | Russian Federation | A3 | |
| US2020397806A1 | United States of America | A1 | |
| JP6880006B2 | Japan | B2 | |
| US11033564B2 | United States of America | B2 | |
| RU2749865C2 | Russian Federation | C2 | |
| JP2021107452A | Japan | A | |
| US2022168326A1 | United States of America | A1 | |
| IL257531BThis record | Israel | B | |
| IL298438A | Israel | A | |
| IL257531B2 | Israel | B2 | |
| CN108601828B | China | B | |
| AU2016323968B2 | Australia | B2 | |
| CN116440279A | China | A | |
| JP2023101813A | Japan | A | |
| AU2023233173A1 | Australia | A1 | |
| KR102700777B1 | Republic of Korea | B1 | |
| JP7703593B2 | Japan | B2 | |
| JP2025129187A | Japan | A | |
| IL323626A | Israel | A |
Numbers
- Publication
- 257531
- Application
- 257531
Titles2
- English
- THERAPEUTIC COMBINATIONS COMPRISING ANTI-FOLR1 IMMUNOCONJUGATES
- Hebrew
- צירופים רפואיים המכילים תצמידים חיסוניים אנטי-FOLR1
Classification
- CPC, 30
- A61K31/704
- A61K39/3955
- A61K47/68033
- A61K39/39558
- A61K31/555
- A61K2039/507
- A61K33/243
- A61K33/24
- A61P35/00
- C07K16/28
- A61K47/6849
- A61K2039/545
- C07K2317/565
- A61K45/06
- C07K16/22
- A61K2300/00
- A61K31/537
- C07K2317/31
- C07K2317/56
- C07K2317/622
- C07K2317/732
- C07K2317/92
- A61K47/6851
- A61K47/6869
- A61K2039/505
- C07K2317/24
- C07K2317/73
- C07K2317/75
- C07K16/30
- A61K39/395
- IPC, 8
- A61K39 00
- C07K16 28
- A61K39 395
- A61K45 06
- A61K33 24
- A61K31 704
- A61K31 555
- A61K33 243